SlideShare a Scribd company logo
1 of 29
Pulmonary Renal Syndromes

Zunaira Islam MD PGY3
Jeffrey Cohen MD - Nephrology
Orlando Regional Medical Center
What do the lungs and kidneys have in
               common?


 Detailed and extensive amount of micro-vasculature
  across a large surface area

 Basement membrane (which has special antigens)

 Exchange of materials across a thin barrier.

 Both clean the body of waste material and manage the
  delicate balance of other materials.
Facts to keep in mind



 Pulmonary Renal syndromes can be FATAL.

 If bleeding is occurring from both the lungs and
  kidneys then these patients need to be in the ICU
  and get treatment FAST otherwise they will die.

 In difficult cases with vague symptoms, sometimes
  an early renal biopsy can make all the difference
The basic pathology

LUNGS: Diffuse alveolar hemorrhage (DAH)

    - Acute onset of symptoms
    - 2/3 have at least mild Hemoptysis if not more gross
    bleeding
    - X-ray and CT scans are usually abnormal: Alveolar and
        interstitial opacities, or even fibrosis type appearance
        may be seen
    - If severe – many of them need intubation

KIDNEYS: Rapidly Progressive Glomerlo-Nephritis
      - Acute Renal Failure
      - Oliguria <400ml/day
      - RBC casts and RBC on UA
Causes of Pulmonary Renal Syndromes


 ANCA associated Vasculitis:     ~ 60%
        Wegeners
        Microscopic Polyangitis
        Churg Strauss Syndrome
 Goodpasture‟s syndrome          ~ 20%
OTHERS:
 SLE
 Uremic Lung
 Pneumonia with Infectious GN
ANCA associated Vasculitis

THREE diseases causing Pulmonary Renal Syndromes are ANCA + and
pauci-immune – meaning very few immune complexes involved in the
glomeruli. Mostly T cell mediated injury.

These three together make up 60% of all Pulmonary-Renal Syndromes

1- Wegener‟s Granulomatosis: C-ANCA or Anti-PR3

2- Microscopic Polyangitis: P-ANCA or Anti MPO

3- Churg Straus: P-ANCA or Anti-MPO

Any combination or mix of antibodies is possible but above is basic
underlying pattern.

They have similar treatment – but prognosis is worse if Anti-PR3 is present
C ANCA above   P ANCA below
Wegener’s Granulomatosis
    LUNG, UPPER AIRWAY (sinus, nasopharynx) , and
                     RENAL involvement.
 Necrotizing Vasculitis of SMALL VESSELS (arterioles AND veins)
  .

 Renal Biopsy shows SEGMENTAL NECRTIZING
  Glomerulonephritis and Rapidly Progressive GN in later stages

 Non-Caseating Granuloma formation – rarely in the kidney,
  mostly in lung/sinuses.

 If no renal involvement it is called LMITED Wegeners – but
  kidneys usually get involved later.

 Chest X-Ray may show: Nodules, persistent infiltrates, cavities

 Cause unknown – has been associated with Silica exposure.
Wegener‟s Granulomatosis


 Signs and Symptoms: Fever, Rhinorrhea, Sinus pain, Sinus ulcers,
  Hemoptysis, SOB, Hematuria, Proteinuria, Cutaneous purpura.
 Lung biopsy has highest yield.

 More common in people with apha-1 antitrypsin deficiency 
  which inhibits PR3
 Rx: STEROIDS + CYCLOPHOSPHAMIDE .
 Plasmapharesis is not established - may or may not be used initially
  depending on severity

 25% will relapse  REPEAT ABOVE TREATMENT and give
   Methotrexate OR Azathioprine to maintain remission.
Microscopi polyangitis

 Necrotizing vasculitis, glomerulonephritis, and pulmonary capilaritis.

 Very similar to Wegener‟s Granulomatosis – Except that there are NO
  GRANULOMAS on biopsy.

 Lungs are involved only 50% of the time and upper airway is rarely
  involved – and these involvements are rarely severe

 Used to be included in P.A.N – no longer – involves the lungs – and PAN
  does Not. Also not associated with HBV, but PAN is.

 Can also cause GI vasculitis , cutaneous vasculitis and Mononeurtis
  complex.

 Rx: similar to Wegener‟s – STEROIDS + IMMUNOSUPPRESSANT.
  Plasmapharesis is not established – may or may not be used depending on
  severity.

 Relapse also occurs – 35% of the time – treated the same – repeat and give
  maintenance therapy with MTX or Azathioprine
Churg Strauss Syndrome


 Small vessel vasculitis with focal segmental necrotizing
  glomerulonephritis.

 Rare “allergic state” with systemic inflammation associated with Asthma,
  Hypergammaglobulinemia, RF+, raised IgE levels, and EOSINOPHILS

 Rare: about 1 in 3 million

 Has been associated with Asthma treated with Leukotriene antagonists.

 Symptoms: Lung involvement dominates and may preceded others by
  years: Cough, infiltrates, severe asthma, 1/3 have pleural effusions – high
  in eosinophils.

 GN (45%), Rhinitis, mononeuritis, Skin involvement (50%) , GI vasculitis
  and Cardiovascular inflammation resulting in MI (most frequent cause of
  death in Churg Strauss)
Churg Strauss….

 Kidney biopsy usually does not show granuloma or eosinophils
  (granulomas and eosinophils are present in lung and elsewhere) .
  Do blood tests for Ige, Eosinophils.

 Rx: similar: STEROIDS + IMMUNOSUPRESSANTS

 May be difficult to wean off steroids and may become dependant
  on them.
Goodpasture‟s syndrome

 Autoimmune disease with Abs against the “alpha 3
  NC1 domain of TYPE IV COLLAGEN” on the
  basement membrane.

 This epitope becomes „exposed‟ by infections,
  smoking, solvents, and oxidants
 10-15% also have ANCA abs against Myeloperoxidase
  (MPO) – a vasculitis variant which has good prognosis.

 Bimodal Age distribution:
   Men in late 20s
   Men and women 60-70s
Goodpastures syndrome…


Young Men in 20s:
 Explosive, sudden onset.
 Sudden anemia
 More lung involvement than in older age group
   Hemoptysis - specially if smokers
   Dyspnea,
   Hematuria
   Better prognosis than older age group
Goodpasture‟s syndrome…


Older Age Group: 60-70s , M and F

 Prolonged asymptomatic renal injury

 May present with oliguria – Poor prognosis

 Lung disease may range from mild dyspnea to
  outright pulmonary hemorrhage

 Urgent kidney biopsy if we suspect this disease and
  there are mild or no lung signs
Goodpasture‟s syndrome…


DIAGNOSIS:

Renal Biopsy:
– Focal (<50% glomeruli affected)
- or segmental (glomeruli tuft involved in segments)


Linear Immunoflorescence staining
Anti GBM Abs against ALPHA3 -NC1-Collagen IV t
Goodpasture‟s: Linear immunoflorence
Goodpasture‟s syndrome

TREATMENT AND PROGNOSIS:
 Plasmapharesis + Steroids + Immunosuppressants
(and supportive care if needed: ventilator , dialysis)

Signs of Poor Prognosis:
- Biopsy shows >50% crescent and advanced fibrosis,
  (specially seen in long standing asymptomatic disease in
  older folks)
- Cr 5-6 mg/dl
- Oliguria
- If needs urgent dialysis at presntation  may not even
  respond to plasmapheresis or steroids
Goodpasture‟s … treatment and
            prognosis

 Even if kidney disease does not respond to
  plasmapharesis – lung disease does and it can be
  lifesaving.

 8-10 treatments of plasmapharesis is needed

 At the same time Prednisone or IV
  methylprednisolone, PLUS Cyclophosphamide
  should be started together  cyclophosphamide for
  at least first 2 weeks

 Kidney transplant can be considered – but wait 6
  months for antibodies to clear out.
Goodpasture‟s : treatment and prognosis


 If No treatment received  80% risk of ESRD in 1
  year

 If needed urgent Dialysis  may not ever recover
  renal function, need dialysis for life

 Treatment started Early (Cr <5)  One year
  survival is 90%
Dr Goodpasture, 1919
Lupus Nephritis

 Immune complex deposition in the glomeruli + Complement
  cascade activation. If Antiphospholipid antibodies are present
  then thrombotic microangiopathy also occurs

 In Lung: Pleuritis , pleural effusion, diaphragmatic
  dysfunction, atelectasis, pulm vascular disease with pulm
  hemorrhage, uremic pulmonary edema.
Lupus Nephritis ….
Uremic Lung / Uremic Pulmonary Edema

 Occurs in severe renal failure, ESRD , specially when HTN also
  present.
 Due to the actual Uremia itself – usually when Cr Clearance
  <10ml/min. Fluid, electrolyte, metabolic changes – No single toxin
  has been identified as the cause yet.
 There is increase in pulmonary capillary permeability due to uremia
  effects – causing protein rich fluid to enter the lungs from the
  capillaries – causes Uremic Pulmonary Edema.
 CXR shows perihilar edema, though peripheries are clear.
 Correction or uremia with or without Dialysis can correct the flow
  dynamics of the pulmonary vasculature and improve
Uremic lung
Infectious GN


 Very rarely – If Strep pharyngitis and Strep
  pneumonia occur – pulmonary symptoms may still
  be present by the time Renal RPGN starts …
references


 Harrisons

 Multiple websites and article abstracts

More Related Content

What's hot

Approach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGNApproach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGNGarima Aggarwal
 
granulomatosis with polyangiitis (Wegener’s granulomatosis)
granulomatosis with polyangiitis (Wegener’s granulomatosis) granulomatosis with polyangiitis (Wegener’s granulomatosis)
granulomatosis with polyangiitis (Wegener’s granulomatosis) Ameen Rageh
 
Coverted PPT
Coverted PPTCoverted PPT
Coverted PPTAdil
 
Wegener's Granulomatosis
Wegener's Granulomatosis  Wegener's Granulomatosis
Wegener's Granulomatosis Ashraf Hefny
 
Management of tb in ckd dr Tareq tantawy
Management of tb in ckd dr Tareq tantawyManagement of tb in ckd dr Tareq tantawy
Management of tb in ckd dr Tareq tantawyFarragBahbah
 
FlashPath - Lung - Cryptogenic Organizing Pneumonia (Bronchiolitis Obliterans...
FlashPath - Lung - Cryptogenic Organizing Pneumonia (Bronchiolitis Obliterans...FlashPath - Lung - Cryptogenic Organizing Pneumonia (Bronchiolitis Obliterans...
FlashPath - Lung - Cryptogenic Organizing Pneumonia (Bronchiolitis Obliterans...Hazem Ali
 
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)Manjunath Anvekar
 
Granulomatosis polyangitis GPA
Granulomatosis polyangitis GPAGranulomatosis polyangitis GPA
Granulomatosis polyangitis GPAMarwa Besar
 
Alveolar hemorrhage
Alveolar hemorrhageAlveolar hemorrhage
Alveolar hemorrhagePRABHAKAR K
 
Pulmonary manifestations of collagen vascular diseases
Pulmonary manifestations of collagen vascular diseasesPulmonary manifestations of collagen vascular diseases
Pulmonary manifestations of collagen vascular diseasesHemant Kumar Agarwal
 
Progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathyProgressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathyNeurology Residency
 
Allergic Broncho Pulmonary Aspergillosis (ABPA) by Dr.Tinku Joseph
Allergic Broncho Pulmonary Aspergillosis (ABPA) by Dr.Tinku JosephAllergic Broncho Pulmonary Aspergillosis (ABPA) by Dr.Tinku Joseph
Allergic Broncho Pulmonary Aspergillosis (ABPA) by Dr.Tinku JosephDr.Tinku Joseph
 
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)Pratap Tiwari
 

What's hot (20)

Approach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGNApproach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGN
 
granulomatosis with polyangiitis (Wegener’s granulomatosis)
granulomatosis with polyangiitis (Wegener’s granulomatosis) granulomatosis with polyangiitis (Wegener’s granulomatosis)
granulomatosis with polyangiitis (Wegener’s granulomatosis)
 
Minimal change disease
Minimal change diseaseMinimal change disease
Minimal change disease
 
Coverted PPT
Coverted PPTCoverted PPT
Coverted PPT
 
PARA PNEUMONIC EFFUSION
PARA PNEUMONIC EFFUSIONPARA PNEUMONIC EFFUSION
PARA PNEUMONIC EFFUSION
 
Wegener's Granulomatosis
Wegener's Granulomatosis  Wegener's Granulomatosis
Wegener's Granulomatosis
 
Pulmonary vasculitis
Pulmonary vasculitisPulmonary vasculitis
Pulmonary vasculitis
 
Management of tb in ckd dr Tareq tantawy
Management of tb in ckd dr Tareq tantawyManagement of tb in ckd dr Tareq tantawy
Management of tb in ckd dr Tareq tantawy
 
FlashPath - Lung - Cryptogenic Organizing Pneumonia (Bronchiolitis Obliterans...
FlashPath - Lung - Cryptogenic Organizing Pneumonia (Bronchiolitis Obliterans...FlashPath - Lung - Cryptogenic Organizing Pneumonia (Bronchiolitis Obliterans...
FlashPath - Lung - Cryptogenic Organizing Pneumonia (Bronchiolitis Obliterans...
 
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
 
Granulomatosis polyangitis GPA
Granulomatosis polyangitis GPAGranulomatosis polyangitis GPA
Granulomatosis polyangitis GPA
 
Anca vasculitis & anti gbm
Anca vasculitis & anti gbmAnca vasculitis & anti gbm
Anca vasculitis & anti gbm
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 
Alveolar hemorrhage
Alveolar hemorrhageAlveolar hemorrhage
Alveolar hemorrhage
 
Pulmonary manifestations of collagen vascular diseases
Pulmonary manifestations of collagen vascular diseasesPulmonary manifestations of collagen vascular diseases
Pulmonary manifestations of collagen vascular diseases
 
Progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathyProgressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy
 
Allergic Broncho Pulmonary Aspergillosis (ABPA) by Dr.Tinku Joseph
Allergic Broncho Pulmonary Aspergillosis (ABPA) by Dr.Tinku JosephAllergic Broncho Pulmonary Aspergillosis (ABPA) by Dr.Tinku Joseph
Allergic Broncho Pulmonary Aspergillosis (ABPA) by Dr.Tinku Joseph
 
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
 
Pleural Effusion
Pleural EffusionPleural Effusion
Pleural Effusion
 
Hypersensitivity pneumonitis
Hypersensitivity pneumonitisHypersensitivity pneumonitis
Hypersensitivity pneumonitis
 

Viewers also liked (20)

Approach to a patient with vasculitis
Approach to a patient with vasculitisApproach to a patient with vasculitis
Approach to a patient with vasculitis
 
Approach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsApproach to a patient with vasculitis and its
Approach to a patient with vasculitis and its
 
Alport
AlportAlport
Alport
 
Renal amyloidosis
Renal amyloidosisRenal amyloidosis
Renal amyloidosis
 
Cardiorenal syndrome
Cardiorenal syndromeCardiorenal syndrome
Cardiorenal syndrome
 
Cutaneous Vasculitis
Cutaneous VasculitisCutaneous Vasculitis
Cutaneous Vasculitis
 
Vasculitis syndromes
Vasculitis syndromesVasculitis syndromes
Vasculitis syndromes
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Vasculitis Overview
Vasculitis OverviewVasculitis Overview
Vasculitis Overview
 
2 pulmonary edema pattern (symmetric bilateral alveolar
2 pulmonary edema pattern (symmetric bilateral alveolar2 pulmonary edema pattern (symmetric bilateral alveolar
2 pulmonary edema pattern (symmetric bilateral alveolar
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Manifestaciones pulmonares de las enfermedades sistémicas
Manifestaciones pulmonares de las enfermedades sistémicasManifestaciones pulmonares de las enfermedades sistémicas
Manifestaciones pulmonares de las enfermedades sistémicas
 
Vasculitis 2015 undergraduate
Vasculitis 2015 undergraduateVasculitis 2015 undergraduate
Vasculitis 2015 undergraduate
 
Vasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBMVasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBM
 
Cardiorenal syndrome DR Osama EL-Shahat
Cardiorenal syndrome   DR Osama EL-ShahatCardiorenal syndrome   DR Osama EL-Shahat
Cardiorenal syndrome DR Osama EL-Shahat
 
Introducing Sociology (1 of 2)
Introducing Sociology (1 of 2)Introducing Sociology (1 of 2)
Introducing Sociology (1 of 2)
 
Renal vasculitis
Renal vasculitisRenal vasculitis
Renal vasculitis
 
Alports Syndrome Pp
Alports Syndrome PpAlports Syndrome Pp
Alports Syndrome Pp
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Cardiorenal syndrome
Cardiorenal syndromeCardiorenal syndrome
Cardiorenal syndrome
 

Similar to Pulmonary Renal Syndromes

Endoscopic Laser surgery For Subglottic Stenosis in Wegerners Granulomatosis ...
Endoscopic Laser surgery For Subglottic Stenosis in Wegerners Granulomatosis ...Endoscopic Laser surgery For Subglottic Stenosis in Wegerners Granulomatosis ...
Endoscopic Laser surgery For Subglottic Stenosis in Wegerners Granulomatosis ...MedicineAndHealthResearch
 
GLOMERULONEPHRITIS disease description pptx
GLOMERULONEPHRITIS disease description pptxGLOMERULONEPHRITIS disease description pptx
GLOMERULONEPHRITIS disease description pptxAmos830559
 
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxD. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxhussainAltaher
 
The heart and collagen vascular disorders
The heart and collagen vascular disordersThe heart and collagen vascular disorders
The heart and collagen vascular disordersDr. Rajesh Das
 
20100603 acute glomerulonephritis
20100603 acute glomerulonephritis20100603 acute glomerulonephritis
20100603 acute glomerulonephritisSumit Prajapati
 
Secondary glomerular disorders.pptx
Secondary glomerular disorders.pptxSecondary glomerular disorders.pptx
Secondary glomerular disorders.pptxfarahalamleh
 
Vasculits syndrome
Vasculits syndromeVasculits syndrome
Vasculits syndromeRahul Arya
 
19 Acute Glomerulonephritis
19 Acute Glomerulonephritis19 Acute Glomerulonephritis
19 Acute Glomerulonephritisghalan
 
pulmonary embolism
pulmonary embolismpulmonary embolism
pulmonary embolismaravazhi
 
Pulmonary Manifestations of SLE.pptxpt
Pulmonary Manifestations of SLE.pptxptPulmonary Manifestations of SLE.pptxpt
Pulmonary Manifestations of SLE.pptxptdrnomanmalikdnm
 
SARCOIDOSIS vs TB.pptx
SARCOIDOSIS vs TB.pptxSARCOIDOSIS vs TB.pptx
SARCOIDOSIS vs TB.pptxGouriMohan7
 
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptxDr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptxdramit13
 

Similar to Pulmonary Renal Syndromes (20)

Endoscopic Laser surgery For Subglottic Stenosis in Wegerners Granulomatosis ...
Endoscopic Laser surgery For Subglottic Stenosis in Wegerners Granulomatosis ...Endoscopic Laser surgery For Subglottic Stenosis in Wegerners Granulomatosis ...
Endoscopic Laser surgery For Subglottic Stenosis in Wegerners Granulomatosis ...
 
GLOMERULONEPHRITIS disease description pptx
GLOMERULONEPHRITIS disease description pptxGLOMERULONEPHRITIS disease description pptx
GLOMERULONEPHRITIS disease description pptx
 
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxD. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
 
ANCA GN.pptx
ANCA GN.pptxANCA GN.pptx
ANCA GN.pptx
 
The heart and collagen vascular disorders
The heart and collagen vascular disordersThe heart and collagen vascular disorders
The heart and collagen vascular disorders
 
VTE Final.pptx
VTE Final.pptxVTE Final.pptx
VTE Final.pptx
 
20100603 acute glomerulonephritis
20100603 acute glomerulonephritis20100603 acute glomerulonephritis
20100603 acute glomerulonephritis
 
Secondary glomerular disorders.pptx
Secondary glomerular disorders.pptxSecondary glomerular disorders.pptx
Secondary glomerular disorders.pptx
 
Ns
NsNs
Ns
 
Vasculits syndrome
Vasculits syndromeVasculits syndrome
Vasculits syndrome
 
19 Acute Glomerulonephritis
19 Acute Glomerulonephritis19 Acute Glomerulonephritis
19 Acute Glomerulonephritis
 
pulmonary embolism
pulmonary embolismpulmonary embolism
pulmonary embolism
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
 
Dr.cazaam
Dr.cazaamDr.cazaam
Dr.cazaam
 
Pulmonary Manifestations of SLE.pptxpt
Pulmonary Manifestations of SLE.pptxptPulmonary Manifestations of SLE.pptxpt
Pulmonary Manifestations of SLE.pptxpt
 
SARCOIDOSIS vs TB.pptx
SARCOIDOSIS vs TB.pptxSARCOIDOSIS vs TB.pptx
SARCOIDOSIS vs TB.pptx
 
Ac nephritic synd
Ac nephritic syndAc nephritic synd
Ac nephritic synd
 
APS in daily practice 2022.pdf
APS in daily practice 2022.pdfAPS in daily practice 2022.pdf
APS in daily practice 2022.pdf
 
APS IN daily practice.pdf
APS IN daily practice.pdfAPS IN daily practice.pdf
APS IN daily practice.pdf
 
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptxDr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
Dr. Amit Anand ANTIPHOSPHOLIPD SYNDROME ( APLA ).pptx
 

Recently uploaded

How to Add a Tool Tip to a Field in Odoo 17
How to Add a Tool Tip to a Field in Odoo 17How to Add a Tool Tip to a Field in Odoo 17
How to Add a Tool Tip to a Field in Odoo 17Celine George
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024Elizabeth Walsh
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxDr. Ravikiran H M Gowda
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxPooja Bhuva
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfDr Vijay Vishwakarma
 
Introduction to TechSoup’s Digital Marketing Services and Use Cases
Introduction to TechSoup’s Digital Marketing  Services and Use CasesIntroduction to TechSoup’s Digital Marketing  Services and Use Cases
Introduction to TechSoup’s Digital Marketing Services and Use CasesTechSoup
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSCeline George
 
dusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningdusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningMarc Dusseiller Dusjagr
 
How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17Celine George
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfPondicherry University
 
Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Celine George
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxJisc
 
Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of PlayPooky Knightsmith
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSAnaAcapella
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsSandeep D Chaudhary
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...EADTU
 

Recently uploaded (20)

How to Add a Tool Tip to a Field in Odoo 17
How to Add a Tool Tip to a Field in Odoo 17How to Add a Tool Tip to a Field in Odoo 17
How to Add a Tool Tip to a Field in Odoo 17
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Introduction to TechSoup’s Digital Marketing Services and Use Cases
Introduction to TechSoup’s Digital Marketing  Services and Use CasesIntroduction to TechSoup’s Digital Marketing  Services and Use Cases
Introduction to TechSoup’s Digital Marketing Services and Use Cases
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...
 
dusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningdusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learning
 
How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
 
Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17
 
Our Environment Class 10 Science Notes pdf
Our Environment Class 10 Science Notes pdfOur Environment Class 10 Science Notes pdf
Our Environment Class 10 Science Notes pdf
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Play hard learn harder: The Serious Business of Play
Play hard learn harder:  The Serious Business of PlayPlay hard learn harder:  The Serious Business of Play
Play hard learn harder: The Serious Business of Play
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
 

Pulmonary Renal Syndromes

  • 1. Pulmonary Renal Syndromes Zunaira Islam MD PGY3 Jeffrey Cohen MD - Nephrology Orlando Regional Medical Center
  • 2. What do the lungs and kidneys have in common?  Detailed and extensive amount of micro-vasculature across a large surface area  Basement membrane (which has special antigens)  Exchange of materials across a thin barrier.  Both clean the body of waste material and manage the delicate balance of other materials.
  • 3. Facts to keep in mind  Pulmonary Renal syndromes can be FATAL.  If bleeding is occurring from both the lungs and kidneys then these patients need to be in the ICU and get treatment FAST otherwise they will die.  In difficult cases with vague symptoms, sometimes an early renal biopsy can make all the difference
  • 4. The basic pathology LUNGS: Diffuse alveolar hemorrhage (DAH) - Acute onset of symptoms - 2/3 have at least mild Hemoptysis if not more gross bleeding - X-ray and CT scans are usually abnormal: Alveolar and interstitial opacities, or even fibrosis type appearance may be seen - If severe – many of them need intubation KIDNEYS: Rapidly Progressive Glomerlo-Nephritis - Acute Renal Failure - Oliguria <400ml/day - RBC casts and RBC on UA
  • 5. Causes of Pulmonary Renal Syndromes  ANCA associated Vasculitis: ~ 60% Wegeners Microscopic Polyangitis Churg Strauss Syndrome  Goodpasture‟s syndrome ~ 20% OTHERS:  SLE  Uremic Lung  Pneumonia with Infectious GN
  • 6. ANCA associated Vasculitis THREE diseases causing Pulmonary Renal Syndromes are ANCA + and pauci-immune – meaning very few immune complexes involved in the glomeruli. Mostly T cell mediated injury. These three together make up 60% of all Pulmonary-Renal Syndromes 1- Wegener‟s Granulomatosis: C-ANCA or Anti-PR3 2- Microscopic Polyangitis: P-ANCA or Anti MPO 3- Churg Straus: P-ANCA or Anti-MPO Any combination or mix of antibodies is possible but above is basic underlying pattern. They have similar treatment – but prognosis is worse if Anti-PR3 is present
  • 7. C ANCA above P ANCA below
  • 8.
  • 9. Wegener’s Granulomatosis LUNG, UPPER AIRWAY (sinus, nasopharynx) , and RENAL involvement.  Necrotizing Vasculitis of SMALL VESSELS (arterioles AND veins) .  Renal Biopsy shows SEGMENTAL NECRTIZING Glomerulonephritis and Rapidly Progressive GN in later stages  Non-Caseating Granuloma formation – rarely in the kidney, mostly in lung/sinuses.  If no renal involvement it is called LMITED Wegeners – but kidneys usually get involved later.  Chest X-Ray may show: Nodules, persistent infiltrates, cavities  Cause unknown – has been associated with Silica exposure.
  • 10. Wegener‟s Granulomatosis  Signs and Symptoms: Fever, Rhinorrhea, Sinus pain, Sinus ulcers, Hemoptysis, SOB, Hematuria, Proteinuria, Cutaneous purpura.  Lung biopsy has highest yield.  More common in people with apha-1 antitrypsin deficiency  which inhibits PR3  Rx: STEROIDS + CYCLOPHOSPHAMIDE .  Plasmapharesis is not established - may or may not be used initially depending on severity  25% will relapse  REPEAT ABOVE TREATMENT and give Methotrexate OR Azathioprine to maintain remission.
  • 11. Microscopi polyangitis  Necrotizing vasculitis, glomerulonephritis, and pulmonary capilaritis.  Very similar to Wegener‟s Granulomatosis – Except that there are NO GRANULOMAS on biopsy.  Lungs are involved only 50% of the time and upper airway is rarely involved – and these involvements are rarely severe  Used to be included in P.A.N – no longer – involves the lungs – and PAN does Not. Also not associated with HBV, but PAN is.  Can also cause GI vasculitis , cutaneous vasculitis and Mononeurtis complex.  Rx: similar to Wegener‟s – STEROIDS + IMMUNOSUPPRESSANT. Plasmapharesis is not established – may or may not be used depending on severity.  Relapse also occurs – 35% of the time – treated the same – repeat and give maintenance therapy with MTX or Azathioprine
  • 12. Churg Strauss Syndrome  Small vessel vasculitis with focal segmental necrotizing glomerulonephritis.  Rare “allergic state” with systemic inflammation associated with Asthma, Hypergammaglobulinemia, RF+, raised IgE levels, and EOSINOPHILS  Rare: about 1 in 3 million  Has been associated with Asthma treated with Leukotriene antagonists.  Symptoms: Lung involvement dominates and may preceded others by years: Cough, infiltrates, severe asthma, 1/3 have pleural effusions – high in eosinophils.  GN (45%), Rhinitis, mononeuritis, Skin involvement (50%) , GI vasculitis and Cardiovascular inflammation resulting in MI (most frequent cause of death in Churg Strauss)
  • 13. Churg Strauss….  Kidney biopsy usually does not show granuloma or eosinophils (granulomas and eosinophils are present in lung and elsewhere) . Do blood tests for Ige, Eosinophils.  Rx: similar: STEROIDS + IMMUNOSUPRESSANTS  May be difficult to wean off steroids and may become dependant on them.
  • 14. Goodpasture‟s syndrome  Autoimmune disease with Abs against the “alpha 3 NC1 domain of TYPE IV COLLAGEN” on the basement membrane.  This epitope becomes „exposed‟ by infections, smoking, solvents, and oxidants  10-15% also have ANCA abs against Myeloperoxidase (MPO) – a vasculitis variant which has good prognosis.  Bimodal Age distribution:  Men in late 20s  Men and women 60-70s
  • 15. Goodpastures syndrome… Young Men in 20s:  Explosive, sudden onset.  Sudden anemia  More lung involvement than in older age group  Hemoptysis - specially if smokers  Dyspnea,  Hematuria  Better prognosis than older age group
  • 16. Goodpasture‟s syndrome… Older Age Group: 60-70s , M and F  Prolonged asymptomatic renal injury  May present with oliguria – Poor prognosis  Lung disease may range from mild dyspnea to outright pulmonary hemorrhage  Urgent kidney biopsy if we suspect this disease and there are mild or no lung signs
  • 17. Goodpasture‟s syndrome… DIAGNOSIS: Renal Biopsy: – Focal (<50% glomeruli affected) - or segmental (glomeruli tuft involved in segments) Linear Immunoflorescence staining Anti GBM Abs against ALPHA3 -NC1-Collagen IV t
  • 19. Goodpasture‟s syndrome TREATMENT AND PROGNOSIS: Plasmapharesis + Steroids + Immunosuppressants (and supportive care if needed: ventilator , dialysis) Signs of Poor Prognosis: - Biopsy shows >50% crescent and advanced fibrosis, (specially seen in long standing asymptomatic disease in older folks) - Cr 5-6 mg/dl - Oliguria - If needs urgent dialysis at presntation  may not even respond to plasmapheresis or steroids
  • 20. Goodpasture‟s … treatment and prognosis  Even if kidney disease does not respond to plasmapharesis – lung disease does and it can be lifesaving.  8-10 treatments of plasmapharesis is needed  At the same time Prednisone or IV methylprednisolone, PLUS Cyclophosphamide should be started together  cyclophosphamide for at least first 2 weeks  Kidney transplant can be considered – but wait 6 months for antibodies to clear out.
  • 21. Goodpasture‟s : treatment and prognosis  If No treatment received  80% risk of ESRD in 1 year  If needed urgent Dialysis  may not ever recover renal function, need dialysis for life  Treatment started Early (Cr <5)  One year survival is 90%
  • 23. Lupus Nephritis  Immune complex deposition in the glomeruli + Complement cascade activation. If Antiphospholipid antibodies are present then thrombotic microangiopathy also occurs  In Lung: Pleuritis , pleural effusion, diaphragmatic dysfunction, atelectasis, pulm vascular disease with pulm hemorrhage, uremic pulmonary edema.
  • 25. Uremic Lung / Uremic Pulmonary Edema  Occurs in severe renal failure, ESRD , specially when HTN also present.  Due to the actual Uremia itself – usually when Cr Clearance <10ml/min. Fluid, electrolyte, metabolic changes – No single toxin has been identified as the cause yet.  There is increase in pulmonary capillary permeability due to uremia effects – causing protein rich fluid to enter the lungs from the capillaries – causes Uremic Pulmonary Edema.  CXR shows perihilar edema, though peripheries are clear.  Correction or uremia with or without Dialysis can correct the flow dynamics of the pulmonary vasculature and improve
  • 27. Infectious GN  Very rarely – If Strep pharyngitis and Strep pneumonia occur – pulmonary symptoms may still be present by the time Renal RPGN starts …
  • 28.
  • 29. references  Harrisons  Multiple websites and article abstracts